Ratings by Roth Capital

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/29/2015 Celldex Therapeutics CLDX Maintain Buy
(N/A)
43.00
(N/A)
      Details
6/29/2015 Sarepta Therapeutic SRPT Maintain Buy
(N/A)
45.00
(N/A)
      Details
1,169 more...